SOURCE: EP Global Communications, Inc.

March 09, 2007 09:00 ET

EP Global Communications, Inc. Signs an Agreement With Valeant Pharmaceuticals to Develop a Multimedia Educational Program on Epilepsy

JOHNSTOWN, PA -- (MARKET WIRE) -- March 9, 2007 -- EP Global Communications, Inc. (OTCBB: EPGL) today announced that it has signed a sponsorship agreement with Valeant Pharmaceuticals for the development of an educational program aimed at increasing awareness among families, caregivers, teachers, nurses, physicians, and allied health care professionals on the necessity for having a seizure preparedness plan. This program will be created primarily by EP Global Communications, Inc., the parent company of Exceptional Parent (EP) magazine, with the support of Vemics Inc., an EP Global Communications, Inc. partner that produces live, interactive, TV-quality programs online. The program will be offered under the EP LiveOnline™ educational brand.

This multi-media program has three main features. The first is the production of an online-based interactive teleconference entitled, "Contemporary Issues in the Diagnosis and Management of Epilepsy in Children and Adults: The Need for a Seizure Preparedness Plan." The educational program will involve the participation of families and professionals, as well as that of various epilepsy organizations, including chapters of the Epilepsy Foundation. Plans for the seminar include the invitation of distinguished professionals to take part in the event, which is slated to take place in June 2007.

The second feature of the overall educational program involves the packaging and distribution of a special epilepsy report, along with EP magazine, to members of various professional groups, such as pediatric neurologists, developmental pediatricians and key members of the American Academy of Developmental Medicine and Dentistry as well as several major military installations around the world.

Third among the multimedia features of the program is the planned incorporation of the special epilepsy report on the EP website (, which is being re-launched in April of 2007 to reach a wider audience with improved connectivity features.

About EP Global Communications, Inc.

EP Global Communications, parent company of Exceptional Parent (EP) magazine, is a 36-year-old, award-winning publishing and communications company which provides practical advice and emotional support to families of children and adults with disabilities and special health care needs -- as well as the physicians, allied health care and educational professionals who are involved in their care and development. EP uses a multi-media approach to disseminate information via: its monthly award-winning publication, Exceptional Parent; web site (; clinical custom communications projects; the EP Library Bookstore ( of disability books, DVDs and videos; live and on-line interactive CME/CEU accredited Seminars & Teleconferences on a wide range of special needs topics in the chronic long-term disabilities and special needs community.

About Vemics, Inc.

Vemics, Inc. is a leading provider of hosted, real-time collaboration and learning applications. Vemics LiveAccess™ solutions combine multipoint video/voice and data technologies with industry-specific content, consulting expertise and deep customer support enabling organizations large and small to work, collaborate and learn face-to-face, online from almost anywhere with little or no capital investment. Vemics NuScribe™ provides voice-activated solutions for physician transcription and electronic medical record creation. Vemics is based in New York with offices in Boston, Philadelphia and Austin.

Safe Harbor Statement

Certain matters discussed in this press release are "forward-looking statements" intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. In particular, the Company's statements regarding trends in the marketplace and potential future results are examples of such forward-looking statements. The forward-looking statements include risks and uncertainties, including, but not limited to, the timing of projects due to the variability in size, scope and duration of projects, estimates made by management with respect to the Company's critical accounting policies, regulatory delays, clinical study results which lead to reductions or cancellations of projects, and other factors, including general economic conditions and regulatory developments, not within the Company's control. The factors discussed herein and expressed from time to time in the Company's filings with the Securities and Exchange Commission could cause actual results and developments to be materially different from those expressed in or implied by such statements. The forward-looking statements are made only as of the date of this press release and the Company undertakes no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

Contact Information